INDIRECT COMPARISON OF DARATUMUMAB MONOTHERAPY VERSUS REAL-WORLD HISTORICAL CONTROL DATA IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE HEAVILY PRE-TREATED AND HIGHLY REFRACTORY

被引：1
|
作者：
Diels, J. [1 ]
Lam, A. [2 ]
Ito, T. [3 ]
Ng, Y. [2 ]
Mehra, M. [2 ]
Khan, I [4 ]
机构：
[1] Janssen Hlth Econ & Market Access EMEA Stat & Mod, Beerse, Belgium
[2] Janssen Global Serv LLC, Raritan, NJ USA
[3] Janssen Hlth Econ & Market Access EMEA, High Wycombe, Bucks, England
[4] Janssen Res & Dev LLC, Raritan, NJ USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1659
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN37
引用
收藏
页码：A140 / A140
页数：1
相关论文
共 50 条
  • [1] ADJUSTED COMPARISON OF DARATUMUMAB MONOTHERAPY VERSUS REAL-WORLD HISTORICAL CONTROL DATA FROM THE CZECH REPUBLIC IN HEAVILY PRE-TREATED AND HIGHLY REFRACTORY MULTIPLE MYELOMA PATIENTS
    Diels, J.
    Gatopoulou, X.
    Besson, H.
    Vesela, S.
    Hajek, R.
    Jarkovsky, J.
    Ito, T.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A711 - A711
  • [2] Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients
    Jelinek, Tomas
    Maisnar, Vladimir
    Pour, Ludek
    Spicka, Ivan
    Minarik, Jiri
    Gregora, Evzen
    Kessler, Petr
    Sykora, Michal
    Frankova, Hana
    Adamova, Dagmar
    Wrobel, Marek
    Mikula, Peter
    Jarkovsky, Jiri
    Diels, Joris
    Gatopoulou, Xenia
    Vesela, Sarka
    Besson, Herve
    Brozova, Lucie
    Ito, Tetsuro
    Hajek, Roman
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (05) : 775 - 783
  • [3] DARATUMUMAB MONOTHERAPY COMPARED WITH REAL-WORLD HISTORICAL CONTROL DATA IN HEAVILY PRETREATED PATIENTS WITH HIGHLY REFRACTORY MULTIPLE MYELOMA: AN ADJUSTED TREATMENT COMPARISON
    Diels, J.
    Lam, A.
    Ito, T.
    Mehra, M.
    Khan, I.
    [J]. HAEMATOLOGICA, 2016, 101 : 521 - 521
  • [4] Comparative Effectiveness of Daratumumab Monotherapy Versus a Real-World Historical Control from the Czech Republic in Heavily Pretreated and Highly Refractory Multiple Myeloma Patients
    Hajek, Roman
    Jelinek, Tomas
    Maisnar, Vladimir
    Pour, Ludek
    Spicka, Ivan
    Minarik, Jiri
    Gregora, Evzen
    Kessler, Petr
    Sykora, Michal
    Frankova, Hana
    Adamova, Dagmar
    Wrobel, Marek
    Mikula, Peter
    Jarkovsky, Jiri
    Gatopoulou, Xenia
    Vesela, Sarka
    Diels, Joris
    Besson, Herve
    Brozova, Lucie
    Ito, Tetsuro
    [J]. BLOOD, 2016, 128 (22)
  • [5] Daratumumab Monotherapy for Heavily Pre-treated and Refractory Myeloma: Results from a UK Multicentre Real World Cohort
    Maouche, Nadjoua
    Srinivasan, Anandagopal
    Leary, Heather
    Collings, Freya
    Tseu, Bing
    Vallance, Grant D.
    Ramasamy, Karthik
    Kothari, Jaimal
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, : 299 - 304
  • [6] Daratumumab monotherapy compared with historical control data in heavily pretreated and highly refractory patients with multiple myeloma: An adjusted treatment comparison
    Usmani, Saad Z.
    Diels, Joris
    Ito, Tetsuro
    Mehra, Maneesha
    Khan, Imran
    Lam, Annette
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E146 - E152
  • [7] Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma
    Salomon-Perzynski, Aleksander
    Walter-Croneck, Adam
    Usnarska-Zubkiewicz, Lidia
    Dytfeld, Dominik
    Zielinska, Patrycja
    Wojciechowska, Malgorzata
    Holojda, Jadwiga
    Robak, Pawel
    Pasternak, Anna
    Knopinska-Posluszny, Wanda
    Hawrylecka, Dorota
    Wojtowicz, Marcin
    Szeremet, Agnieszka
    Osowiecki, Michal
    Mordak-Domagala, Monika
    Zaucha, Jan Maciej
    Giannopoulos, Krzysztof
    Warzocha, Krzysztof
    Jamroziak, Krzysztof
    [J]. ADVANCES IN MEDICAL SCIENCES, 2019, 64 (02): : 349 - 355
  • [8] Daratumumab Monotherapy in Heavily Pretreated Asian Patients With Relapsed and Refractory Multiple Myeloma: A Real-world Experience
    Byun, Ja Min
    Yoon, Sung-Soo
    Koh, Youngil
    Kim, Inho
    Jo, Jaemin
    Park, Hyunkyung
    Lee, Jeong-Ok
    Lee, Jiyun
    [J]. ANTICANCER RESEARCH, 2019, 39 (09) : 5165 - 5170
  • [9] A Real-World Study of Bendamustine Therapy in a Very Heavily Pre-Treated Population of Multiple Myeloma Patients
    Bird, Sarah
    Panopoulou, Akaterina
    Kaiser, Martin
    Boyd, Kevin
    Pawlyn, Charlotte
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S424 - S424
  • [10] Bendamustine in heavily pre-treated patients with relapsed or refractory multiple myeloma
    Stoehr, Elisabeth
    Schmeel, Frederic Carsten
    Schmeel, Leonard Christopher
    Haenel, Mathias
    Schmidt-Wolf, Ingo G. H.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (12) : 2205 - 2212
12345